National Library of Medicine; Notice of Meetings, 101612-101613 [2024-29560]
Download as PDF
<![CDATA[
101612
Federal Register / Vol. 89, No. 241 / Monday, December 16, 2024 / Notices
Address: National Institutes of Health
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852.
Meeting Format: Virtual Meeting.
Contact Person: Andrea B. Kelly, Ph.D.,
Scientific Review Officer, National Institute
on Deafness and Other Communication
Disorders, National Institutes of Health, 6001
Executive Boulevard, Room 8351, Bethesda,
MD 20892, (301) 451–6339, kellya2@nih.gov.
Name of Committee: Communication
Disorders Review Committee.
Date: February 20–21, 2025.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: Hilton Garden Inn Orlando at
SeaWorld Orlando, FL.
Meeting Format: In Person and Virtual
Meeting.
Contact Person: Katherine Shim, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, NIDCD, NIH, 6001
Executive Blvd., Bethesda, MD 20892, 301–
496–8683, shimk@nidcd.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.173, Biological Research
Related to Deafness and Communicative
Disorders, National Institutes of Health, HHS)
Dated: December 11, 2024.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–29558 Filed 12–13–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
lotter on DSK11XQN23PROD with NOTICES1
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting of the National
Institute of Biomedical Imaging and
Bioengineering Special Emphasis Panel.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel; P41 NCBIB Review
D–SEP.
Date: March 4–7, 2024.
Time: 9:00 a.m. to 1:00 p.m.
VerDate Sep<11>2014
17:41 Dec 13, 2024
Jkt 265001
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Democracy II, Suite 920, 6707 Democracy
Blvd., Bethesda, MD 20817 (Virtual Meeting).
Contact Person: John Hayes, Ph.D.,
Scientific Review Officer, National Institute
of Biomedical Imaging and Bioengineering,
National Institutes of Health, 6707
Democracy Blvd., Bethesda, MD 20892, (301)
451–3398, john.hayes@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, National Institute of
Biomedical Imaging and Bioengineering,
National Institutes of Health.)
Dated: December 11, 2024.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory
Committee Policy.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: December 11, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–29540 Filed 12–13–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
[FR Doc. 2024–29551 Filed 12–13–24; 8:45 am]
National Library of Medicine; Notice of
Meetings
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Trial Net Hub and
Coordinating Center Cooperative Agreement
(U01) Application Review.
Date: February 28, 2025.
Time: 12:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
National Institute of Diabetes and Digestive
and Kidney Diseases, Democracy II, Suite
7000A, 6707 Democracy Boulevard,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Cheryl Nordstrom, Ph.D.,
MPH, Scientific Review Officer, Scientific
Review Branch, National Institute of Diabetes
and Digestive and Kidney Diseases, National
Institutes of Health, 6707 Democracy
Boulevard, Room 7013, Bethesda, MD 20892,
301–402–6711, cheryl.nordstrom@nih.gov.
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting.
The meeting will be open to the
public as indicated below. Individuals
who plan to attend and need special
assistance, such as sign language
interpretation or other reasonable
accommodations should notify the
Contact Person listed below in advance
of the meeting.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), title 5 U.S.C., as amended for
review, discussion, and evaluation of
individual intramural programs and
projects conducted by the National
Library of Medicine, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Library of
Medicine Board of Scientific Counselors.
Date: April 30, 2025.
Open: 9:00 a.m. to 10:20 p.m.
Agenda: Program Discussion and
Investigator Report.
Closed: 10:20 p.m. to 11:45 a.m.
Agenda: To review and evaluate personal
qualifications, performance, and competence
of individual investigators.
Open: 11:45 a.m. to 12:30 p.m.
Agenda: Program Discussion and
Investigator Report.
Closed: 12:30 p.m. to 2:00 p.m.
Agenda: To review and evaluate personal
qualifications, performance, and competence
of individual investigators.
Open: 2:00 p.m. to 2:45 p.m.
Agenda: Program Discussion and
Investigator Report.
Place: National Library of Medicine, 8600
Rockville Pike, Bethesda, MD 20892 (Inperson and Virtual Meeting).
E:\FR\FM\16DEN1.SGM
16DEN1
Federal Register / Vol. 89, No. 241 / Monday, December 16, 2024 / Notices
Contact Person: David Landsman, Ph.D.,
Branch Chief, National Library of Medicine,
National Institutes of Health, 8600 Rockville
Pike, Bethesda, MD 20894, 301–435–5981,
landsman@mail.nih.gov.
Any member of the public may submit
written comments no later than 15 days in
advance of the meeting. Any interested
person may file written comments with the
committee by forwarding the statement to the
Contact Person listed on this notice. The
statement should include the name, address,
telephone number and when applicable, the
business or professional affiliation of the
interested person.
Open sessions will be videocast and can be
accessed from the NIH Videocasting and
Podcasting website (https://videocast.nih.gov/
) on April 30, 2025. Please direct any
questions to the Contact Person listed on this
notice.
(Catalogue of Federal Domestic Assistance
Program No. 93.879, Medical Library
Assistance, National Institutes of Health,
HHS)
Dated: December 11, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–29560 Filed 12–13–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
lotter on DSK11XQN23PROD with NOTICES1
Periodically, the Substance Abuse and
Mental Health Services Administration
(SAMHSA) will publish a summary of
information collection requests under
OMB review, in compliance with the
Paperwork Reduction Act (44 U.S.C.
chapter 35). To request a copy of these
documents, call the SAMHSA Reports
Clearance Officer on (240) 276–0361.
Proposed Project: Treatment Episode
Data Set (TEDS) (OMB No. 0930–
0335)—Revision
The Center for Behavioral Health
Statistics and Quality (CBHSQ) at the
Substance Abuse and Mental Health
Services Administration (SAMHSA) is
requesting an extension with changes to
the combined data collection of the
Treatment Episode Data Set (TEDS), the
Mental Health Client Level Data (MH–
CLD), and the Mental Health Treatment
Episode Data Set (MH–TEDS) (OMB No.
0930–0335), which expires on December
31, 2024.
TEDS collects episode-level data on
clients aged 12 and older receiving
substance use treatment services from
VerDate Sep<11>2014
17:41 Dec 13, 2024
Jkt 265001
publicly funded facilities. MH–CLD
collects demographic, clinical, and
National Outcome Measures data on
clients receiving mental health and
support services funded or operated by
the State Mental Health Agencies
(SMHAs). MH–TEDS is an alternative
reporting method to MH–CLD. It
collects episode-level data on clients
receiving mental health treatment
services from publicly funded facilities.
MH–TEDS data can be converted to
MH–CLD format.
Under section 505 of the Public
Health Service Act (42 U.S.C. 290aa–4),
CBHSQ is authorized to collect annual
data on the national incidence and
prevalence of the various forms of
mental illness and substance abuse.
CBHSQ is also authorized to collect data
on the number and variety of public and
nonprofit private mental health and
substance use treatment programs and
the number and demographic
characteristics of individuals receiving
treatment through such programs. In
addition, States, receiving fundings
from SAMHSA’s Community Mental
Health Services Block Grant (MHBG)
and Substance Use Prevention,
Treatment, and Recovery Services Block
Grant (SUPTRS BG) (formally known as
the Substance Abuse Prevention and
Treatment Block Grant [SABG]), utilize
TEDS and MH–CLD/MH–TEDS data to
meet the block grant reporting mandate
and requirement.
SAMHSA is requesting OMB approval
of revisions to the TEDS/MH–CLD/MH–
TEDS data collections, to include
changes to the following instruments:
Proposed Changes to TEDS/MH–TEDS
• Add a combined TEDS/MH–TEDS
State Crosswalk to map the data
elements, codes, and categories in the
state system to the appropriate TEDS/
MH–TEDS data elements, codes, and
categories; to obtain contextual
information, including state data
collection protocol and reporting
capabilities and data footnotes; and to
collect information on the state TEDS/
MH–TEDS reporting characteristics,
framework, and scope.
• Add Fentanyl and Xylazine in the
list of Detailed Drug Code to improve
the comprehensiveness and greater
details of the substance recorded.
• Remove the term ‘‘Crack’’ from the
existing option of ‘‘Cocaine/Crack’’
under the ‘‘Substance Use’’ data field.
• Revise existing ‘‘Gender’’ data field
to ‘‘Sex’’ and add ‘‘Sexual Orientation’’
and ‘‘Gender Identity’’ (SOGI) as
optional data fields to provide inclusive
measures. These revisions align with
both SAMHSA’s efforts in enhancing
behavioral health equities among
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
101613
diverse populations and the BG
Reporting requirement (OMB No. 0930–
0168). All SUPTRS BG tables which
collect/report SOGI information have
been updated.
• Revise terms with negative
connotations to non-stigmatizing terms.
Examples include changing the word
‘‘abuse’’ to ‘‘use,’’ ‘‘detoxification’’ to
‘‘withdrawal management,’’ and
‘‘Medication-Assisted Opioid Therapy’’
to ‘‘Medications for Opioid Use
Disorder.’’ These revisions align with
the current edition of The Diagnostic
and Statistical Manual of Mental
Disorders (5th ed., American Psychiatric
Association, 2013), and the White
House Office of National Drug Control
Policy 2017 Memo on ‘‘Changing
Federal Terminology regarding
Substance Use and Substance Use
Disorders.’’
• Original ‘‘TEDS and MH–TEDS/
MH–CLD Admission and Update/
Discharge Data Elements’’ form with
combined TEDS/MH–TEDS and MH–
CLD data elements is separated into two
documents to be more user friendly and
improve clarity. Data elements are
reorganized in the order of the code
number to facilitate clearer mapping.
Other minor modifications are made to
enhance language consistency and
clarity. For example, all ‘‘SABG’’ are
updated to ‘‘SUPTRS BG.’’
Proposed Changes to MH–CLD
• Add the MH–CLD State Crosswalk
to map the data elements, codes, and
categories in the state system to the
appropriate MH–CLD data elements,
codes, and categories; to obtain
contextual information, including state
data collection protocol and reporting
capabilities, and data footnotes; and to
collect information the state MH–CLD
reporting characteristics, framework,
and scope.
• Revise existing ‘‘Gender’’ data field
to ‘‘Sex’’ and add SOGI as optional
reporting data fields to provide
inclusive measures. These revisions
align with both SAMHSA’s efforts in
enhancing behavioral health equities
among diverse populations and the BG
Reporting requirement (OMB No. 0930–
0168). All MHBG tables and related URS
tables which collect/report SOGI
information have been updated.
• Add a new ‘‘School attendance
status at admission or start of the
reporting period’’ as a required data
field to assess the changes and outcomes
of clients receiving mental health
treatment and support services through
SMHAs.
• Add optional reporting tables for
Type of Funding Support, Mental
E:\FR\FM\16DEN1.SGM
16DEN1
]]>Agencies
[Federal Register Volume 89, Number 241 (Monday, December 16, 2024)]
[Notices]
[Pages 101612-101613]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-29560]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Library of Medicine; Notice of Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting.
The meeting will be open to the public as indicated below.
Individuals who plan to attend and need special assistance, such as
sign language interpretation or other reasonable accommodations should
notify the Contact Person listed below in advance of the meeting.
The meeting will be closed to the public as indicated below in
accordance with the provisions set forth in section 552b(c)(6), title 5
U.S.C., as amended for review, discussion, and evaluation of individual
intramural programs and projects conducted by the National Library of
Medicine, including consideration of personnel qualifications and
performance, and the competence of individual investigators, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: National Library of Medicine Board of
Scientific Counselors.
Date: April 30, 2025.
Open: 9:00 a.m. to 10:20 p.m.
Agenda: Program Discussion and Investigator Report.
Closed: 10:20 p.m. to 11:45 a.m.
Agenda: To review and evaluate personal qualifications,
performance, and competence of individual investigators.
Open: 11:45 a.m. to 12:30 p.m.
Agenda: Program Discussion and Investigator Report.
Closed: 12:30 p.m. to 2:00 p.m.
Agenda: To review and evaluate personal qualifications,
performance, and competence of individual investigators.
Open: 2:00 p.m. to 2:45 p.m.
Agenda: Program Discussion and Investigator Report.
Place: National Library of Medicine, 8600 Rockville Pike,
Bethesda, MD 20892 (In-person and Virtual Meeting).
[[Page 101613]]
Contact Person: David Landsman, Ph.D., Branch Chief, National
Library of Medicine, National Institutes of Health, 8600 Rockville
Pike, Bethesda, MD 20894, 301-435-5981, [email protected].
Any member of the public may submit written comments no later
than 15 days in advance of the meeting. Any interested person may
file written comments with the committee by forwarding the statement
to the Contact Person listed on this notice. The statement should
include the name, address, telephone number and when applicable, the
business or professional affiliation of the interested person.
Open sessions will be videocast and can be accessed from the NIH
Videocasting and Podcasting website (https://videocast.nih.gov/) on
April 30, 2025. Please direct any questions to the Contact Person
listed on this notice.
(Catalogue of Federal Domestic Assistance Program No. 93.879,
Medical Library Assistance, National Institutes of Health, HHS)
Dated: December 11, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-29560 Filed 12-13-24; 8:45 am]
BILLING CODE 4140-01-P
